Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases

Nitin Verma; Kamal Dua; Aparna Sarin

doi:10.1007/978-981-33-6850-7_24

Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases

Nitin Verma
, Kamal Dua
, Aparna Sarin

Chitkara University
University of Technology Sydney
Technology and Environment

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

Lung disease represents a significant medical problem worldwide. They are usually treated by different synthetic drugs. Yet, incessant high-portion of oral and injectable medications may prompt extreme side effects and at this crossroad, there is a requirement of inhaled formulations that encourage successful medication to the pulmonary routes with no adverse effects. Chemicals isolated form plants, i.e. Common phytoconstituents or phytoalexin (for example, plant antimicrobials) have indicated a remarkable treatment cluster with least adverse effects and incredible ability to treat intrapulmonary and extrapulmonary illnesses contrasted with synthetic medications. In addition, the advancement and integration of various sciences, for example, nanoscience, polymer sciences, material science, and molecule designing along with particles shape and size analysis permits further improvement of the treatment capacity and productivity. This chapter highlights the plant-based advanced drug delivery system for the treatment of chronic lung diseases. Moreover, it also facilitates the scientist with some fundamental foundation data to phytochemical profile, plan prerequisites and medication conveyance frameworks.

Original language	English
Title of host publication	Medicinal Plants for Lung Diseases
Subtitle of host publication	A Pharmacological and Immunological Perspective
Publisher	Springer Nature
Pages	557-582
Number of pages	26
ISBN (Electronic)	9789813368507
ISBN (Print)	9789813368491
DOIs	https://doi.org/10.1007/978-981-33-6850-7_24
State	Published - 1 Jan 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Chronic lung disease
Dry particulate powder inhalers
Phytoconstituents
Pulmonary delivery of phytoconstituents

Access to Document

10.1007/978-981-33-6850-7_24

Cite this

@inbook{15a60a48c69a4eefa00e87974762d668,

title = "Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases",

abstract = "Lung disease represents a significant medical problem worldwide. They are usually treated by different synthetic drugs. Yet, incessant high-portion of oral and injectable medications may prompt extreme side effects and at this crossroad, there is a requirement of inhaled formulations that encourage successful medication to the pulmonary routes with no adverse effects. Chemicals isolated form plants, i.e. Common phytoconstituents or phytoalexin (for example, plant antimicrobials) have indicated a remarkable treatment cluster with least adverse effects and incredible ability to treat intrapulmonary and extrapulmonary illnesses contrasted with synthetic medications. In addition, the advancement and integration of various sciences, for example, nanoscience, polymer sciences, material science, and molecule designing along with particles shape and size analysis permits further improvement of the treatment capacity and productivity. This chapter highlights the plant-based advanced drug delivery system for the treatment of chronic lung diseases. Moreover, it also facilitates the scientist with some fundamental foundation data to phytochemical profile, plan prerequisites and medication conveyance frameworks.",

keywords = "Chronic lung disease, Dry particulate powder inhalers, Phytoconstituents, Pulmonary delivery of phytoconstituents",

author = "Nitin Verma and Kamal Dua and Aparna Sarin",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-981-33-6850-7\_24",

language = "English",

isbn = "9789813368491",

pages = "557--582",

booktitle = "Medicinal Plants for Lung Diseases",

publisher = "Springer Nature",

}

TY - CHAP

T1 - Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases

AU - Verma, Nitin

AU - Dua, Kamal

AU - Sarin, Aparna

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Lung disease represents a significant medical problem worldwide. They are usually treated by different synthetic drugs. Yet, incessant high-portion of oral and injectable medications may prompt extreme side effects and at this crossroad, there is a requirement of inhaled formulations that encourage successful medication to the pulmonary routes with no adverse effects. Chemicals isolated form plants, i.e. Common phytoconstituents or phytoalexin (for example, plant antimicrobials) have indicated a remarkable treatment cluster with least adverse effects and incredible ability to treat intrapulmonary and extrapulmonary illnesses contrasted with synthetic medications. In addition, the advancement and integration of various sciences, for example, nanoscience, polymer sciences, material science, and molecule designing along with particles shape and size analysis permits further improvement of the treatment capacity and productivity. This chapter highlights the plant-based advanced drug delivery system for the treatment of chronic lung diseases. Moreover, it also facilitates the scientist with some fundamental foundation data to phytochemical profile, plan prerequisites and medication conveyance frameworks.

AB - Lung disease represents a significant medical problem worldwide. They are usually treated by different synthetic drugs. Yet, incessant high-portion of oral and injectable medications may prompt extreme side effects and at this crossroad, there is a requirement of inhaled formulations that encourage successful medication to the pulmonary routes with no adverse effects. Chemicals isolated form plants, i.e. Common phytoconstituents or phytoalexin (for example, plant antimicrobials) have indicated a remarkable treatment cluster with least adverse effects and incredible ability to treat intrapulmonary and extrapulmonary illnesses contrasted with synthetic medications. In addition, the advancement and integration of various sciences, for example, nanoscience, polymer sciences, material science, and molecule designing along with particles shape and size analysis permits further improvement of the treatment capacity and productivity. This chapter highlights the plant-based advanced drug delivery system for the treatment of chronic lung diseases. Moreover, it also facilitates the scientist with some fundamental foundation data to phytochemical profile, plan prerequisites and medication conveyance frameworks.

KW - Chronic lung disease

KW - Dry particulate powder inhalers

KW - Phytoconstituents

KW - Pulmonary delivery of phytoconstituents

UR - https://www.scopus.com/pages/publications/85160135714

U2 - 10.1007/978-981-33-6850-7_24

DO - 10.1007/978-981-33-6850-7_24

M3 - Chapter

AN - SCOPUS:85160135714

SN - 9789813368491

SP - 557

EP - 582

BT - Medicinal Plants for Lung Diseases

PB - Springer Nature

ER -

Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this